How has been the historical performance of Bayer CropSci.?

Answer:The historical performance of Bayer CropSci shows a consistent growth trajectory in net sales and profits over the years, although recent figures indicate a decline in profitability.

Breakdown:
Bayer CropSci's net sales have increased from 3,167.30 Cr in Mar'19 to 5,473.40 Cr in Mar'25, reflecting a strong upward trend. Total operating income followed a similar pattern, rising to 5,473.40 Cr in Mar'25 from 3,167.30 Cr in Mar'19. However, total expenditure has also risen significantly, reaching 4,783.80 Cr in Mar'25, compared to 2,686.20 Cr in Mar'19. This has impacted the operating profit, which peaked at 1,035.00 Cr in Mar'24 but fell to 809.30 Cr in Mar'25. Profit before tax also saw a decline from 941.40 Cr in Mar'24 to 707.40 Cr in Mar'25, while profit after tax decreased to 568.00 Cr in Mar'25 from 740.50 Cr in Mar'24. The earnings per share (EPS) dropped to 126.5 in Mar'25 from 164.92 in Mar'24. On the balance sheet, total assets increased to 5,236.20 Cr in Mar'25 from 3,808.70 Cr in Mar'20, while total liabilities rose to 5,236.20 Cr in Mar'25, indicating a growing leverage. Cash flow from operating activities decreased significantly to 262.00 Cr in Mar'25 from 951.00 Cr in Mar'24, contributing to a net cash outflow of 271.00 Cr in Mar'25. Overall, while Bayer CropSci has shown growth in sales and assets, recent declines in profit and cash flow raise concerns about its operational efficiency.